The research progress of p38 MAPK and allergic rhinitis.
- Author:
Zhaofang LIU
;
Hongjiang FAN
;
Mingjie PANG
- Publication Type:Journal Article
- MeSH:
Cell Differentiation;
Cell Proliferation;
Cytokines;
Humans;
Inflammation;
MAP Kinase Signaling System;
Rhinitis, Allergic;
metabolism;
p38 Mitogen-Activated Protein Kinases;
metabolism
- From:
Journal of Clinical Otorhinolaryngology Head and Neck Surgery
2015;29(23):2094-2098
- CountryChina
- Language:Chinese
-
Abstract:
Allergic rhinitis is a kind of nasal mucosal chronic noninfectious inflammatory disease, which is caused by an imbalance in the body cytokine network,a number of intracellular signaling pathways being actived. Many studies have shown that mitogen-activated protein kinase (MAPK) involved in the activation process of allergic rhinitis. p38 mitogen-activated protein kinase (MAPK), as one kind of that, plays a key role in the process of inflammatory cells proliferation and differentiation, as well as production of inflammatory cytokines, and involved in airway inflammatory mechanisms of chronic airway disease. In vitro experiments have confirmed that p38 MAPK inhibitors have anti-inflammatory effect by blocking the downstream related response.
